These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 23639321)

  • 1. Relapsed childhood acute lymphoblastic leukaemia.
    Bhojwani D; Pui CH
    Lancet Oncol; 2013 May; 14(6):e205-17. PubMed ID: 23639321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of relapsed acute lymphoblastic leukemia in childhood with conventional and innovative approaches.
    Locatelli F; Moretta F; Rutella S
    Curr Opin Oncol; 2013 Nov; 25(6):707-15. PubMed ID: 24076579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone-marrow relapse in paediatric acute lymphoblastic leukaemia.
    Bailey LC; Lange BJ; Rheingold SR; Bunin NJ
    Lancet Oncol; 2008 Sep; 9(9):873-83. PubMed ID: 18760243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse of acute lymphoblastic leukemia in children in the context of microarray analyses.
    Szczepanek J; Styczyński J; Haus O; Tretyn A; Wysocki M
    Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):61-8. PubMed ID: 21246408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults.
    Hochberg J; El-Mallawany NK; Cairo MS
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S6-13. PubMed ID: 25486958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New approaches to acute lymphoblastic leukemia in adults: where do we go?
    Hoelzer D; Gökbuget N
    Semin Oncol; 2000 Oct; 27(5):540-59. PubMed ID: 11049022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factors.
    Yan CH; Wang JZ; Liu DH; Xu LP; Chen H; Liu KY; Huang XJ
    Eur J Haematol; 2013 Oct; 91(4):304-14. PubMed ID: 23837640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapeutic strategies in acute lymphoblastic leukaemia relapsing after stem cell transplantation.
    Blair A; Goulden NJ; Libri NA; Oakhill A; Pamphilon DH
    Blood Rev; 2005 Nov; 19(6):289-300. PubMed ID: 16275419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
    Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
    Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia.
    Huck K; Laws HJ; Meisel R; Traeger A; Bernbeck B; Schonberger S; Stackelberg VA; Pape H; Dilloo D
    Haematologica; 2006 May; 91(5 Suppl):ECR07. PubMed ID: 16709515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia.
    Eckert C; Biondi A; Seeger K; Cazzaniga G; Hartmann R; Beyermann B; Pogodda M; Proba J; Henze G
    Lancet; 2001 Oct; 358(9289):1239-41. PubMed ID: 11675066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?
    Balduzzi A; Di Maio L; Silvestri D; Songia S; Bonanomi S; Rovelli A; Conter V; Biondi A; Cazzaniga G; Valsecchi MG
    Br J Haematol; 2014 Feb; 164(3):396-408. PubMed ID: 24422724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
    Henze G; v Stackelberg A; Eckert C
    Klin Padiatr; 2013 May; 225 Suppl 1():S73-8. PubMed ID: 23700062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy for childhood acute lymphoblastic leukemia.
    Cassano WF; Eskenazi AE; Frantz CN
    Curr Opin Oncol; 1993 Jan; 5(1):42-52. PubMed ID: 8427893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype.
    Franca R; Rebora P; Athanasakis E; Favretto D; Verzegnassi F; Basso G; Tommasini A; Valsecchi MG; Decorti G; Rabusin M
    Pharmacogenomics; 2014 Apr; 15(5):619-27. PubMed ID: 24798719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.
    Locatelli F; Zecca M; Messina C; Rondelli R; Lanino E; Sacchi N; Uderzo C; Fagioli F; Conter V; Bonetti F; Favre C; Porta F; Giorgiani G; Pession A
    Leukemia; 2002 Nov; 16(11):2228-37. PubMed ID: 12399966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Towards cure for all children with acute lymphoblastic leukemia?].
    Baruchel A; Leblanc T; Auclerc MF; Schaison G; Leverger G
    Bull Acad Natl Med; 2009 Oct; 193(7):1509-17. PubMed ID: 20669632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT.
    Spyridonidis A; Labopin M; Schmid C; Volin L; Yakoub-Agha I; Stadler M; Milpied N; Socie G; Browne P; Lenhoff S; Sanz MA; Aljurf M; Mohty M; Rocha V;
    Leukemia; 2012 Jun; 26(6):1211-7. PubMed ID: 22290066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose cytarabine and aclarubicin combined with granulocyte colony-stimulating factor for the treatment of relapsed or primary refractory acute lymphocytic leukemia: a retrospective study of 25 Chinese patients.
    Xue SL; Cui HX; Zou JY; Xue MX; Tang XW; Zhang YM; Wu DP
    Hematol Oncol; 2013 Dec; 31(4):206-12. PubMed ID: 23616245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.